What Drug Helps People with MS Walk? An Overview of Dalfampridine (Ampyra)
•
5 min read
Dalfampridine, marketed under the brand name Ampyra in the United States, is an oral medication specifically approved by the FDA to improve walking in adults with multiple sclerosis (MS). In clinical trials, this was demonstrated by an increase in walking speed, a significant outcome for many living with MS.
